Emerald Health Therapeutics and HYTN Cannabis to Launch Cannabis Beverages in Canada
Vancouver, British Columbia--(Newsfile Corp. - November 3, 2021) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQX: EMHTF) ("Emerald") and HYTN Cannabis Inc. ("HYTN") have signed a definitive agreement under which Emerald will co-launch, sell and distribute HYTN's proprietary new sparkling cannabis beverages, which employ fast-acting Elevation Technology®, across Canada. This partnership will leverage Emerald's established cannabis sales license, sales team and infrastructure, and...
2021-11-03 7:00 AM EDT
Emerald Health Therapeutics Strategic Licensee, FlowerPod, Unveils Groundbreaking Dose-Controlled Cannabis Vaping Product, New Brand, and U.S. Launch Plans
Vancouver, British Columbia--(Newsfile Corp. - October 28, 2021) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQX: EMHTF) ("Emerald") announces that its partner, FlowerPod LLC, has completed product development related to a new form of cannabis consumption, a first-of-its-kind cannabis vaporizer puck, created a new brand called HUUETM, and established a partnership with Grenco Science, the leader in advanced cannabis vaporization technology, to provide a go-to-market strategy. As...
2021-10-28 7:00 AM EDT
Emerald Health Therapeutics Announces Chief Financial Officer Transition
Vancouver, British Columbia--(Newsfile Corp. - September 10, 2021) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQX: EMHTF) ("Emerald") announced today that its Chief Financial Officer, Jenn Hepburn, will be stepping down from her position at Emerald, effective October 15, 2021, to pursue other interests. She will continue in her role until that time to help with transition-related activities."Jenn's effort has been pivotal in the implementation of strong financial systems and controls,...
2021-09-10 4:15 PM EDT
Emerald Health Therapeutics Reports 2021 Second Quarter Financial Results and Provides Corporate Update
Vancouver, British Columbia--(Newsfile Corp. - August 31, 2021) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQX: EMHTF) ("Emerald") has released its financial results for the three and six months ended June 30, 2021. Full versions of Emerald's unaudited condensed interim consolidated financial statements and management discussion and analysis can be found on www.sedar.com."In the second quarter we started to see incremental progress in executing on our renewed business strategy,...
2021-08-31 7:00 AM EDT
Emerald Health Therapeutics to Host 2021 Second Quarter Financial Results Conference Call on Tuesday, August 31, 2021 at 10:30 AM ET
Vancouver, British Columbia--(Newsfile Corp. - August 25, 2021) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQX: EMHTF) ("Emerald") today announced that it will report its financial results for the second quarter ended June 30, 2021, after the market close on Monday, August 30, 2021. The company will host a conference call on Tuesday, August 31, 2021, at 10:30 a.m. ET.To access the audio broadcast, please dial (866) 652-5200, or via the internet at:...
2021-08-25 7:00 AM EDT
Emerald Health Therapeutics Comments on Board Resignation
Vancouver, British Columbia--(Newsfile Corp. - August 11, 2021) - Further to its press release of August 6th, Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQX: EMHTF) ("Emerald" or the "Company") provides additional details regarding the resignation of Dr. Avtar Dhillon as director and executive chairman. On August 5th the Company became aware that Dr. Avtar Dhillon had been arrested in the United States and charged with violations of US federal securities laws with respect to trading in...
2021-08-11 4:01 PM EDT
Emerald Health Therapeutics Hires VP Sales & Marketing
Vancouver, British Columbia--(Newsfile Corp. - August 10, 2021) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQX: EMHTF) ("Emerald") has appointed Nick Mosgrove as VP Sales & Marketing. Mr. Mosgrove has over 15 years of sales and marketing leadership experience in the Canadian alcohol beverage and cannabis sectors.Most recently Mr. Mosgrove was VP Sales & Marketing for TerrAscend Canada. In this role he developed and implemented a commercial plan that resulted in 1500+ retail accounts...
2021-08-10 7:00 AM EDT
Emerald Health Therapeutics Executive Chairman Avtar Dhillon Resigns
Vancouver, British Columbia--(Newsfile Corp. - August 6, 2021) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQX: EMHTF) ("Emerald") today announced that Avtar Dhillon, MD, has resigned from his roles as director and Executive Chairman of Emerald's board of directors for personal reasons effective immediately."We would like to thank Dr. Dhillon for his significant contributions to the building of Emerald and wish him all the best in his future endeavors," said Jim Heppell, incoming...
2021-08-06 7:24 PM EDT
Emerald Health Therapeutics Retains Listing Agent to Sell Previously-Closed Greater Vancouver Cannabis Cultivation Facility
Vancouver, British Columbia--(Newsfile Corp. - July 23, 2021) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQX: EMHTF) ("Emerald") has retained BC Farm & Ranch Realty Corp., a real estate agent dedicated 100% to agricultural properties, to assist in the sale of its licensed greenhouse cannabis production facility in Greater Vancouver, British Columbia.As previously announced, Emerald ceased operations at this facility on March 31, 2021, and continues to operate its defined-scale...
2021-07-23 4:47 PM EDT
Emerald Health Therapeutics Launches Fuse(TM) Lifestyle Brand with Fast-Acting Cannabis-Infused Beverage
Vancouver, British Columbia--(Newsfile Corp. - July 21, 2021) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQX: EMHTF) ("Emerald") has introduced its new Fuse™ lifestyle brand and latest product line, the Nano Shot, a flavoured cannabis-infused beverage formulated with 10 mg of THC and a nanoemulsion formulation that assures consumers of a more predictable, rapid onset and shorter controlled duration of effects. Initial shipments of the beverage are available to consumers at licensed...
2021-07-21 7:00 AM EDT
Emerald Health Therapeutics Reports 2021 First Quarter Financial Results and Provides Corporate Update
Vancouver, British Columbia--(Newsfile Corp. - June 1, 2021) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQX: EMHTF) ("Emerald") has released its financial results for the three months ended March 31, 2021. Full versions of Emerald's unaudited condensed interim consolidated financial statements and management discussion and analysis can be found on www.sedar.com."In the year to date, our renewed business plan has become more visibly tangible through the announcement of new business...
2021-06-01 7:00 AM EDT
Emerald Health Therapeutics Signs Letter of Intent for Product Co-Development Agreement with Prima Botanical Wellness Brand
Vancouver, British Columbia--(Newsfile Corp. - May 25, 2021) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQX: EMHTF) ("Emerald") and The Uplifters' Prima, PBC ("Prima"), based in Santa Monica, California, have signed a letter of intent (the "LOI") contemplating joint initiatives to co-develop new cannabinoid-based wellness products for sale in the United States, Canada, and internationally. As an initial step in establishing the relationship, Emerald has made a capital investment in...
2021-05-25 7:00 AM EDT
Emerald Health Therapeutics Licenses New Proprietary Cannabis Dried Flower Format Patent for use in United States
Vancouver, British Columbia--(Newsfile Corp. - May 6, 2021) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQX: EMHTF) ("Emerald") has entered into a license agreement (the "Agreement") with FlowerPod LLC ("FP"), a private US company, providing FP with the exclusive use of certain Emerald patented technology for developing and marketing cannabis related products for use in all US states and other key geographies where adult use and/or medical cannabis is legal.The initial prototype product...
2021-05-06 7:00 AM EDT
Emerald Health Therapeutics Appoints Moe Jiwan as Chief Operating Officer
Vancouver, British Columbia--(Newsfile Corp. - May 4, 2021) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQX: EMHTF) ("Emerald") has appointed Mr. Moe Jiwan as Chief Operating Officer effective May 10th.Mr. Jiwan is a data-driven business leader with over 20 years of diverse experience in strategic development, sales and operations management, e-commerce, and developing data and business intelligence solutions. Before joining Emerald, he served in senior leadership positions, including...
2021-05-04 7:00 AM EDT
Emerald Health Therapeutics Reports 2020 Year-end and Fourth Quarter Financial Results and Provides Corporate Update
Vancouver, British Columbia--(Newsfile Corp. - May 3, 2021) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQX: EMHTF) ("Emerald") has released its financial results for the 12 months ended December 31, 2020. Full versions of Emerald's audited consolidated financial statements and management discussion and analysis were filed on SEDAR today at 7:00 ET and will be available at www.sedar.com."We ended 2020 with a complete transformation of Emerald's balance sheet and operating overhead, and...
2021-05-03 7:10 AM EDT
Emerald Health Therapeutics Confirms Effective Listing Date on Canadian Securities Exchange
Vancouver, British Columbia--(Newsfile Corp. - April 23, 2021) - Emerald Health Therapeutics, Inc. (TSXV: EMH) (OTCQX: EMHTF) ("Emerald" or "the Company") has received final approval to list its common shares (the "Common Shares") on the Canadian Securities Exchange (the "CSE"). The Company will voluntarily delist its Common Shares from the TSX Venture Exchange (the "TSXV") after market close on Monday, April 26, 2021. The Common Shares will commence trading on the CSE under the same symbol,...
2021-04-23 7:00 AM EDT
Emerald Health Therapeutics Establishes Partnership with Spanish Greenhouse Grower for GMP-Certified Cannabis
Vancouver, British Columbia--(Newsfile Corp. - March 17, 2021) - Emerald Health Therapeutics, Inc. (TSXV: EMH) (OTCQX: EMHTF) ("Emerald") has formed a partnership with Medical Plants SLU, based in Almeria, Spain, in which it will provide resources and expertise to assist Medical Plants to produce medical cannabis dried flower and 2.0 products to serve emerging legal medical cannabis markets in the EU and other countries that require high-grade GMP-certified flower or derivatives. Medical...
2021-03-17 7:00 AM EDT
Emerald Health Therapeutics Announces Intention to List on Canadian Securities Exchange
Vancouver, British Columbia--(Newsfile Corp. - March 9, 2021) - Emerald Health Therapeutics, Inc. (TSXV: EMH) (OTCQX: EMHTF) ("Emerald") today announced that it has applied to the Canadian Securities Exchange ("CSE") to have its common shares listed for trading on the CSE. In connection with the listing of its common shares on the CSE, Emerald will apply to the TSX Venture Exchange ("TSXV") to have its common shares delisted from trading on the TSXV.Listing its common shares on the CSE will...
2021-03-09 7:00 AM EST
Emerald Health Therapeutics to Close Greater Vancouver Production Facility
Vancouver, British Columbia--(Newsfile Corp. - February 18, 2021) - Emerald Health Therapeutics, Inc. (TSXV: EMH) (OTCQX: EMHTF) ("Emerald") today announced that it will cease operations at its cannabis production facility in Greater Vancouver, British Columbia effective March 31, 2021 and will consider strategic alternatives for this facility. "Closing our Greater Vancouver production facility is part of Emerald's revised business strategy and transition away from the value segment of the...
2021-02-18 4:45 PM EST
Emerald Health Therapeutics Receives $20.5M Payment from Village Farms and Outlines Growth Plans
Vancouver, British Columbia--(Newsfile Corp. - February 9, 2021) - Emerald Health Therapeutics, Inc. (TSXV: EMH) (OTCQX: EMHTF) ("Emerald") has received from Village Farms International Inc. $19.9M plus $621,534.25 in interest, representing full repayment of the promissory note issued by Village Farms to Emerald as part of its purchase of Emerald's interest in the Pure Sunfarms joint venture which closed in November 2020. This was the final payment due as part of this transaction. "After...
2021-02-09 7:00 AM EST